Cross-modal co-occurrence analysis of nonverbal behavior and content words, vocal emotion and prosody in individuals with subclinical depression.

Background: Most related research focuses on a single variable of verbal and nonverbal behaviors independently without considering their associations. Therefore, it is important to understand subclinical depression in the entire population.

Aims: This study investigated the cross-modal co-occurrence of nonverbal behavior with vocal emotions, prosody, and content words in individuals with subclinical depression.

Insights into an Amorphous NiCoB Nanoparticle-Catalyzed MgH System for Hydrogen Storage.

In the paper, we synthesized amorphous NiCoB nanoparticles by a simple chemical reduction method and employed them as high-activity catalysts to considerably improve the hydrogen storage properties of MgH. The MgH-NiCoB composite quickly absorbed 3.6 wt % H at a low temperature of 85 °C and released 5.

Constructing MgCo-MgCoH nano hydrogen pumps from LiCoO nanosheets for boosting the hydrogen storage property of MgH.

Herein, an active positive electrode material, LiCoO nanosheets, was synthesized a two-step method, which demonstrated a remarkable catalytic effect for the hydrogen storage property of MgH. Incorporated with LiCoO nanosheets, MgH started to release hydrogen at 180 °C and a desorption content as high as 5.5 wt% H was attained within 60 min at 250 °C.

Potential of D-cycloserine in the treatment of behavioral and neuroinflammatory disorders in Parkinson's disease and studies that need to be performed before clinical trials.

Hyperactivation of glutamatergic N-methyl-D-aspartate (NMDA) receptors has been implicated in the excitotoxicity and pathophysiology of Parkinson's disease (PD). NMDA receptor blockers have been used clinically to treat dementia, but their efficacy is controversial. Modulation of NMDA receptors might improve neuroinflammation and cognitive deficits in PD.

Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model.

Hyperactivity of the glutamatergic system is involved in excitotoxicity and neurodegeneration in Parkinson's disease (PD). Metabotropic glutamate receptor subtype 5 (mGluR5) modulates glutamatergic transmission and thus has been proposed as a potential target for neuroprotective drugs. The aim of this study was to determine the effects of 2-methyl-6-(phenylethynyl)-pyridine (MPEP), an mGluR5 antagonist, on working memory, object recognition, and neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD rat model.

Effects of MK-801 on recognition and neurodegeneration in an MPTP-induced Parkinson's rat model.

Several years after the diagnosis of Parkinson's disease (PD), 20-30% of PD patients develop dementia, known as Parkinson's disease dementia (PDD), the features of which include impairment of short-term memory and recognition function. Hyperactivation of the glutamatergic system is implicated in the neurodegeneration seen in PD. The aim of this study was to determine the effects of MK-801, an N-methyl-d-aspartate (NMDA) receptor antagonist, on short-term memory and object recognition in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD rat animal model.